Renal biopsy pathology in a cohort of patients from southwest Sydney with clinically diagnosed systemic lupus erythematosus

International Journal of Nephrology and Renovascular Disease

Volumn 6, Issue , 2013, Pages 15-26

  Yong, Jim L C ^a   Killingsworth, Murray C ^b   Lai, Ken ^c  

^a CENTRAL SYDNEY AREA HEALTH SERVICE   (Australia)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Electron microscopy; Histology; Immunohistochemistry; Lupus nephritis; SLE; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3C; CREATININE; FIBRINOGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANATOMICAL VARIATION; ANTIBODY DETECTION; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTRON MICROSCOPY; ETHNICITY; FEMALE; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NEPHROTIC SYNDROME; PROTEINURIA; SCHOOL CHILD; SEX DIFFERENCE; UNITED KINGDOM;

EID: 84874368215     PISSN: None     EISSN: 11787058     Source Type: Journal    
DOI: 10.2147/IJNRD.S34357     Document Type: Article

References (26)

1. Hochberg MC. Updating the American College of Rheumatology revised criteria for the Classification of Systemic Lupus Erythematosus. Arthritis Rheum. 1997;40(9):1725.
2. Yong JLC, Warren BA. A practical approach to the diagnosis of renal disease by biopsy. Pathology. 1994;26(4):370-396.
3. Churg J, Bernstein J, Glassock RJ. Renal Diseases: Classification and Atlas of Glomerular Diseases, 2nd ed. New York: Igaku-Shoin Medical Publishers; 1995.
4. Weening JJ, D'Agati V, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521-530.
5. McCluskey RT. Lupus Nephritis. In: Kidney Pathology Decennial 1966-1975. Sommers SC, editor. New York: Appleton-Century-Crofts; 1975:435-489.
6. Korbet SM, Schwartz MM, Evans J, Lewis EJ. Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol. 2007; 18(1):244-254.
7. Leaker B, Fairley KF, Dowling J, Kincaid-Smith P. Lupus nephritis: clinical and pathological correlation. QJM. 1987;62(238):163-179.
8. Patel M, Clarke AM, Bruce IN, Symmons DPM. The prevalence and incidence of biopsy-proven lupus nephritis in the UK. Arthritis and Rheum. 2006;54(9):2963-2969.
9. Ong C, Nicholls K, Becker G. Ethnicity and lupus nephritis - an Australian single centre study. Intern Med J. 2010. [Epub ahead of print.]
10. Ginzler EM, Nicastri AD, Chen CK, et al. Progression of mesangial and focal to diffuse lupus nephritis. N Engl J Med. 1974;29(14):693-696.
11. Lu J, Tam LS, Lai FM, et al. Repeat renal biopsy in lupus nephritis: a change in histological pattern is common. Am J Nephrol. 2011;34(3): 220-225.
12. Elder G, Perl S, Yong JLC, Fletcher J, Mackie J. Progression from Goodpasture's disease to membranous glomerulonephritis. Pathology. 1995;27(3):233-236.
13. Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int. 1994;45(2):544-550.
14. Hertig A, Droz D, Lesavre P, Grünfeld J P, Rieu P. SLE and idiopathic nephrotic syndrome: coincidence or not? Am J Kidney Dis. 2002;40(6): 1179-1184.
15. Banf G, Bertani T, Boeri V, et al. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo studio della Nefrite Lupica (GISNEL). Am J Kidney Dis. 1991;18(2): 240-248.
16. Silva F, editor. The Nephropathies of Systemic Lupus Erythematosus. New York: Churchill-Livingstone; 1983.
17. Giannakakis K, Faraggiana T. Histopathology of lupus nephritis. Clin Rev Allergy Immunol. 2011;40(3):170-180.
18. Yu F, Wu LH, Tan Y, et al. Tubulointerstitial lesions of patients with lupus nephritis classifed by the 2003 International Society of Neph- rology and Renal Pathology Society system. Kidney Int. 2010;77(9): 820-829.
19. Solinger AM. Drug-related lupus. Clinical and etiologic considerations, Rheum Dis Clin North Am. 1988;14(1):187-202.
20. D'Agati V, Appel GB. HIV infection and the kidney. J Am Soc Nephrol. 1997;8(1):138-152.
21. Worrall JG, Snaith ML, Batchelor JR, Isenberg DA. SLE: A Rheuma- tological view. Analysis of the clinical features, serology and immu- nogenics of 100 SLE patients during long term follow up. QJM. 1990; 74(275):319-330.
22. Zimmerman R, Radhakrishnan J, Valeri A, Appel G. Advances in treatment of lupus nephritis. Annul Rev Med. 2001;52:63-78.
23. Stone JH. End-stage renal disease in lupus: Disease activity, dialysis and the outcome of transplantation. Lupus. 1998;7(9):654-659.
24. Datta SK, Manny N, Andrzejewski C, André-Schwartz J, Schwartz RS. Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand Black mice I - Xenotropic virus. J Exp Med. 1978;147(3): 854-871.
25. Buckman KJ, Moore SK, Ebbin AJ, Cox MB, Dubois EL. Familial systemic lupus erythematosus. Arch Intern Med. 1978;138(11): 1674-1676.
26. Ortega LM, Schultz DR, Lenz O, Pardo V, Contreras GN. Review: Lupus nephritis: pathologic features, epidemiology and guide to thera- peutic decisions. Lupus. 2010;19(5):557-574.